Analysis on the Correlation Between RUNX3 Mislocalization and Epigenetic Parameters in Non-Small Cell Lung Cancer

被引：0
|
作者：
Liu, W. [1 ,2 ]
Huang, C. [1 ,3 ]
Shi, Y. [4 ,5 ]
Lu, J. [4 ]
Chen, X. [1 ,2 ,5 ]
机构：
[1] Fujian Med Univ, Grad Sch, Fuzhou, Fujian, Peoples R China
[2] Fujian Med Univ, Dept Thorac Surg, Fujian Canc Hosp, Clin Oncol Sch, Fuzhou, Fujian, Peoples R China
[3] Fujian Med Univ, Clin Oncol Sch, Lab Immunooncol, Fujian Canc Hosp, Fuzhou, Fujian, Peoples R China
[4] Fujian Med Univ, Dept Pathol, Clin Oncol Sch, Fujian Canc Hosp, Fuzhou, Fujian, Peoples R China
[5] Fuzhou Univ, Interdisciplinary Inst Med Engn, Fuzhou, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
runt-related transcription factor 3; promoter hypermethylation; non-small cell lung cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP.02B.06
引用
收藏
页码：S438 / S439
页数：2
相关论文
共 50 条
  • [1] Loss of expression rather than cytoplasmic mislocalization of RUNX3 predicts worse outcome in non-small cell lung cancer
    Chen, Xiaohui
    Deng, Yujie
    Shi, Yi
    Zhu, Weifeng
    Cai, Yibin
    Xu, Chunwei
    Zhu, Kunshou
    Zheng, Xiongwei
    Chen, Gang
    Xie, Qi
    Weng, Guoxing
    ONCOLOGY LETTERS, 2018, 15 (04) : 5043 - 5055
  • [2] Loss of Expression Rather Than Cytoplasmic Mislocalization of RUNX3 Predicts Worse Outcome in Non-Small Cell Lung Cancer
    Chen, X.
    Deng, Y.
    Shi, Y.
    Zhu, W.
    Zhu, K.
    Zheng, X.
    Lin, G.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S725 - S726
  • [3] Association between RUNX3 promoter methylation and non-small cell lung cancer: a meta-analysis
    Liang, Yali
    He, Lianping
    Yuan, Hui
    Jin, Yuelong
    Yao, Yingshui
    JOURNAL OF THORACIC DISEASE, 2014, 6 (06) : 694 - 705
  • [4] Application of RUNX3 gene promoter methylation in the diagnosis of non-small cell lung cancer
    Yu, Gui-Ping
    Ji, Yong
    Chen, Guo-Qiang
    Huang, Bin
    Shen, Kai
    Wu, Song
    Shen, Zhen-Ya
    ONCOLOGY LETTERS, 2012, 3 (01) : 159 - 162
  • [5] Clinicopathological significance and potential drug target of RUNX3 in non-small cell lung cancer: a meta-analysis
    Xu, Lijun
    Lan, Hongwen
    Su, Yushu
    Li, Jun
    Wan, Jingwen
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 2855 - 2865
  • [6] MicroRNA-661 promotes non-small cell lung cancer progression by directly targeting RUNX3
    Wang, Yu
    Li, Yuqiang
    Wu, Bin
    Shi, Ce
    Li, Chen
    MOLECULAR MEDICINE REPORTS, 2017, 16 (02) : 2113 - 2120
  • [7] Epigenetic inactivation of the RUNX3 gene in lung cancer
    Sato, K
    Tomizawa, Y
    Iijima, H
    Saito, R
    Ishizuka, T
    Nakajima, T
    Mori, M
    ONCOLOGY REPORTS, 2006, 15 (01) : 129 - 135
  • [8] Immunohistochemical analysis of non-small cell lung cancer: Correlation with clinical parameters and prognosis
    Yoo, Jinyoung
    Jung, Ji Han
    Lee, Myung A.
    Seo, Kyung Jin
    Shim, Byoung Yong
    Kim, Sung Hwan
    Cho, Deog Gon
    Ahn, Myeong Im
    Kim, Chi Hong
    Cho, Kyu Do
    Kang, Seok Jin
    Kim, Hoon Kyo
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2007, 22 (02) : 318 - 325
  • [9] RUNX3 is frequently inactivated in human breast cancer by protein mislocalization and epigenetic gene silencing
    Miyamoto, Kazuaki
    Ito, Kosei
    Ushijima, Toshikazu
    Koseki, Masato
    Motoshita, Junichi
    Ito, Yoshiaki
    Tahara, Eiichi
    Taniyama, Kiyomi
    CANCER RESEARCH, 2006, 66 (08)
  • [10] The correlation between hemostatic parameters and mortality rate in patients with non-small cell lung cancer
    Soeroso, Noni Novisari
    Ananda, Fannie Rizki
    Samosir, Ganda
    Hariman, Herman
    Eyanoer, Putri Chairani
    HEMATOLOGY REPORTS, 2021, 13 (03)
12345